The stock is currently trading below $4.5, 1.44 times the book value per share. Book value is important ... term downturn if Trump rekindles the 2018 China trade war this year.

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

Asian equities rebounded, and tariff talk became more bark than bite for Canada and Mexico as the U.S. dollar fell.

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

Merck posted Q4 sales of $15.62 billion, driven by Keytruda's 19% growth. FY25 guidance lags estimates, citing Gardasil ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Tesla unveils new Model Y in China, featuring upgraded design and comfort, to regain market share from competitors like Xiaomi Tesla launched a new version of the Model Y, its best-selling car ...

BEIJING, Feb 2 (Reuters) - China's government on Sunday denounced the Trump administration's imposition of a long-threatened 10% tariff on Chinese imports while leaving the door open for talks ...

DeepSeek may not have triggered a sell-off panic for Apple, but the iPhone maker has another China headache. While Apple avoided the pummelling handed to its Silicon Valley peers this week by ...

Wang Yun’an, the 38-year-old founder of Guming Holdings, is on the cusp of becoming a billionaire as his company prepares for an initial public offering in Hong Kong.

DeepSeek’s A.I. models show that China is making rapid gains in the field, despite American efforts to hinder it.